scholarly journals Post liposuction Mycobacterium abscessus surgical site infection in a returned medical tourist complicated by a paradoxical reaction during treatment

2015 ◽  
Vol 7 (4) ◽  
Author(s):  
Siong H. Hui ◽  
Lisa Noonan ◽  
Ruchir Chavada

Rapidly growing mycobacterial skin and soft tissue infections are known to complicate cosmetic surgical procedures. Treatment consists of more surgery and prolonged antibiotic therapy guided by drug susceptibility testing. Paradoxical reactions occurring during antibiotic therapy can further complicate treatment of non-tuberculous mycobacterial infections. We report a case of post liposuction <em>Mycobacterium abscessus</em> surgical site infection in a returned medical tourist and occurrence of paradox during treatment.

2021 ◽  
Author(s):  
Natalia de CARVALHO ◽  
Sylvia LEÃO ◽  
Sidney Bombarda ◽  
Robert D Arbeit ◽  
Erica CHIMARA

Abstract Background: Drug susceptibility testing (DST) of the Mycobacterium abscessus complex (MABSC) and other rapidly growing nontuberculous mycobacteria by conventional broth microdilution (BMD) is complicated due to inducible resistance to clarithromycin and other technical factors. The goals of this study were to develop a protocol for performing DST of MABSC clinical isolates on the BACTEC MGIT 960/Epicenter TB eXiST and provide an initial assessment of its reliability and utility.Methods: M. abscessus ATCC19977 was used as the reference strain for developing the protocol and as the internal control for DST done by BMD method per CLSI guidelines plus resazurin. Both methods were applied to 31 MABSC clinical isolates submitted to our reference center. Genotyping was performed for the rrl and erm(41) genes known to impact clarithromycin resistance phenotype.Results: The 31 MABSC isolates included 14 M. abscessus subsp. abscessus, 8 M. abscessus subsp. massiliense, and 9 M. abscessus subsp. bolletii. By standard BMD method, a high percentage of the isolates were resistant to cefoxitin (93.5%) and imipenem (100%), and sensitive to amikacin (96.7%). Comparing microplate and MGIT 960 results across those 93 pairs of results (31 isolates x 3 antibiotics), 75 (80.6%) were concordant and the remaining 18 (19.4%) represented minor errors; there were no major or very major errors. Concordance was 100% for amikacin, 84% for imipenem, and 58% for cefoxitin. Clarithromycin DST by microplate and MGIT 960 both identified 14 (45.2%) isolates as susceptible. Microplate identified 3 (9.6%) isolates as resistant after 3 days incubation, with 14 (45.2%) demonstrating inducible resistance from Day 5 to 14. Among those 17 isolates, the MGIT 960 protocol, without modifications, reported 9 (29.0%) as resistant and 8 (25.8%) as intermediate. For all isolates, the observed clarithromycin susceptibility phenotypes were consistent with the genotypes. Conclusion: This study details the development of a DST protocol for MABSC isolates using the MGIT 960/Epicenter TB eXiST system. Based on direct comparison with the standard BMD, the protocol provided highly reliable results, including, without further modification, detection of isolates with inducible-resistance to clarithromycin. These findings support proceeding to the multi-laboratory collaborative study required for validation of the protocol.


Author(s):  
Horacio Gil ◽  
Hasmik Margaryan ◽  
Ismailov Azamat ◽  
Bekturdieva Ziba ◽  
Halmuratov Bayram ◽  
...  

2010 ◽  
Vol 5 (1) ◽  
pp. 13-20
Author(s):  
S Acharya ◽  
P Ghimire ◽  
DK Khadka ◽  
S Nepali

Background: Tuberculosis (TB) is among the most serious infectious cause of global morbidity and mortality. Emergence of Multi-drug resistant tuberculosis (MDR-TB) is posing an increased threat to TB control programs. Drug susceptibility testing (DST) of Mycobacterium tuberculosis (M. tuberculosis) isolates is important for tackling such problems. Setting: National Tuberculosis Centre (NTC), Thimi, Bhaktapur, Nepal. Objectives: Comparative evaluation of two in vitro DST methods in determining susceptibility of M. tuberculosis isolates from patients attending NTC, to front-line anti-TB drugs: (Isoniazid-INH, Rifampicin-RFP, Streptomycin-SM, and Ethambutol-EMB). Methodology: This study was conducted from Sep 2006-Jun 2007. A total of 862 sputum samples (diagnosis or follow up cases) collected from patients (type of patients or their categories was not differentiated in this study) attending NTC bacteriology lab for sputum direct smear microscopy were analyzed using fluorescence microscopy. All smear positive samples, smear negative samples requested for culture were cultured. All culture positive samples confirmed as M. tuberculosis by biochemical tests were processed for DST by both proportion (PR) and resistance ratio (RR) methods. Results: Out of 862 sputum samples analyzed, 226 (26.2%) samples were positive for Acid Fast Bacilli (AFB) by fluorescence microscopy. Among 323 samples 226 smear positive samples and 97 smear negative samples requested for culture), 221 (68.4%) were culture positive, 92 (28.5%) were culture negative and 10 (3.1%) were contaminated. Out of 221 isolates of M. tuberculosis, 57.5% were resistant to one or more drugs by the PR method and 56.6% by the RR method. Similarly, MDR isolates were 29.9% and 29% by PR and RR methods respectively. On correlation analysis using Mc Nemar Chi-square test, no significant difference between the two tests were observed (p>0.05). The results showed high agreement between both methods and agreement rates to INH, RFP, SM and EMB were 93.2%, 93.7%, 93.2% and 94.1% respectively. Similarly, the agreement rates between both methods using kappa analysis showed kappa (k) value of 0.86, 0.85, 0.86 and 0.84 for INH, RFP, SM and EMB respectively, which is believed to be good agreement between both methods (k=0.80 to 1.00: Very good agreement). Conclusion: In conclusion, this study showed that both the Proportion and Resistance ratio methods are equally good for determining drug susceptibility of M. tuberculosis. Keywords: Mycobacterium tuberculosis; Drug Susceptibility Testing; Proportion Method; Resistance Ratio Method. DOI: 10.3126/saarctb.v5i1.3078 SAARC J. Tuber. Lung Dis. HIV/AIDS 2008 Vol.5(1) 13-20


2008 ◽  
Vol 53 (2) ◽  
pp. 808-810 ◽  
Author(s):  
Agustina I. de la Iglesia ◽  
Emma J. Stella ◽  
Héctor R. Morbidoni

ABSTRACT Resistance to rifampin (rifampicin), isoniazid, and streptomycin of 69 Mycobacterium tuberculosis isolates was analyzed by an in-house method based on mycobacteriophage D29 and a colorimetric micromethod. Both methods showed sensitivity and specificity values ranging from 93% to 100%. These simple methods offer an option for drug resistance assessment of M. tuberculosis.


Sign in / Sign up

Export Citation Format

Share Document